Ascend Capital’s Merck MRK Stock Holding History

Ascend Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$4.49M	Buy	+66,270	New	+$4.22M	0.23%	104
2018 Q1	–	Sell	-387,370	Closed	-$20.8M	–	247
2017 Q4	$20.8M	Buy	+387,370	New	+$21.5M	0.78%	41
2016 Q4	–	Sell	-313,586	Closed	-$18.7M	–	158
2016 Q3	$18.7M	Buy	+313,586	New	+$18.3M	1.14%	28
2016 Q1	–	Sell	-237,702	Closed	-$12M	–	135
2015 Q4	$12M	Buy	+237,702	New	+$12M	0.42%	75
2015 Q3	–	Sell	-1,151,333	Closed	-$62.5M	–	156
2015 Q2	$62.5M	Buy	+1,151,333	New	+$64.6M	2.06%	9
2014 Q1	–	Sell	-507,770	Closed	-$24.3M	–	214
2013 Q4	$24.3M	Buy	+507,770	New	+$23.2M	0.74%	48
2013 Q3	–	Sell	-471,486	Closed	-$20.9M	–	224
2013 Q2	$20.9M	Buy	+471,486	New	+$21.1M	0.89%	33

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ascend Capital's MRK Position: Q3 2018 in Review

Ascend Capital opened a new position in Merck (MRK) in Q3 2018: 66,270 shares worth $4.49M. The stake represents 0.23% of the portfolio and ranks #104 among its holdings. This is a return to the name: Ascend Capital previously reported a position in MRK as recently as Q4 2017.

Ascend Capital first reported a position in MRK in Q2 2013 and has held it in 7 quarters since. The position peaked at $62.5M in Q2 2015. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

Ascend Capital held 66,270 shares of Merck worth $4.49M as of Q3 2018.
Merck was a new Ascend Capital position in Q3 2018.
Merck made up 0.23% of Ascend Capital's portfolio in Q3 2018, its #104 holding.
Ascend Capital first reported a position in Merck in Q2 2013 and has held it in 7 quarters since.
Ascend Capital's Merck position peaked at $62.5M in Q2 2015.
2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.